Highlights from the ERS International Congress 2018: Assembly 13 - Pulmonary Vascular Diseases.
Journal
ERJ open research
ISSN: 2312-0541
Titre abrégé: ERJ Open Res
Pays: England
ID NLM: 101671641
Informations de publication
Date de publication:
Feb 2019
Feb 2019
Historique:
received:
27
10
2018
accepted:
25
01
2019
entrez:
22
3
2019
pubmed:
22
3
2019
medline:
22
3
2019
Statut:
epublish
Résumé
The 2018 European Respiratory Society (ERS) International Congress in Paris, France, highlighted the subject of pulmonary vascular disease (PVD). 2018 was an exciting year for the PVD community as it was the first ERS International Congress since the formation of Assembly 13, which is dedicated to PVD, pulmonary embolism and the right ventricle. This article aims to summarise the high-quality studies presented at the 2018 Congress into four subject areas: the use of risk stratification in pulmonary arterial hypertension, the molecular mechanisms and treatment of pulmonary hypertension (PH), understanding and improving the right ventricle in PH, and finally, advances in the field of acute pulmonary embolus.
Identifiants
pubmed: 30895188
doi: 10.1183/23120541.00202-2018
pii: 00202-2018
pmc: PMC6421363
pii:
doi:
Types de publication
Editorial
Langues
eng
Déclaration de conflit d'intérêts
Conflict of interest: S. Ramjug has nothing to disclose. Conflict of interest: R. Adão has nothing to disclose. Conflict of interest: R. Lewis has nothing to disclose. Conflict of interest: F. Coste has nothing to disclose. Conflict of interest: F. de Man reports grants from the Netherlands CardioVascular Research Initiative and VENI from the Netherlands Organization for Scientific Research, outside the submitted work. Conflict of interest: D. Jimenez has nothing to disclose. Conflict of interest: O. Sitbon reports grants, personal fees and non-financial support from Actelion, Bayer, GSK and Merek, and personal fees from Acceleron and Arena, outside the submitted work. Conflict of interest: M. Delcroix reports grants and personal fees from Actelion, and personal fees from Bayer, GSK, MSD, Reata, Bellarophon and Eli Lilly, outside the submitted work. Conflict of interest: A. Vonk-Noordegraaf reports personal fees from Actelion and Arena, and grants from the Netherlands CardioVascular Research Initiative, outside the submitted work.
Références
J Heart Lung Transplant. 2015 Mar;34(3):395-403
pubmed: 25499139
Cardiovasc Res. 2018 May 1;114(6):880-893
pubmed: 29360952
Eur Respir J. 2014 Sep;44(3):694-703
pubmed: 24696111
Eur Respir J. 2013 Mar;41(3):588-92
pubmed: 22790909
Lung. 2017 Feb;195(1):9-17
pubmed: 27915422
Arch Intern Med. 2010 Aug 9;170(15):1383-9
pubmed: 20696966
Eur Respir J. 2018 May 10;51(5):
pubmed: 29724918
Eur Respir J. 2017 Aug 3;50(2):
pubmed: 28775050
J Am Coll Cardiol. 2017 Mar 28;69(12):1536-1544
pubmed: 28335835
Am J Respir Crit Care Med. 2018 Jul 1;198(1):90-103
pubmed: 29394093
N Engl J Med. 2015 Dec 24;373(26):2522-33
pubmed: 26699168
Thromb Res. 2018 May;165:107-111
pubmed: 29631073
J Heart Lung Transplant. 2016 Nov;35(11):1321-1329
pubmed: 27241861
Am J Respir Crit Care Med. 2015 Aug 1;192(3):342-55
pubmed: 26039706
Eur Respir J. 2017 Jun 29;49(6):
pubmed: 28663319
Int J Cardiol. 2017 Mar 1;230:214-221
pubmed: 28062137
Curr Opin Pulm Med. 2017 Sep;23(5):377-385
pubmed: 28582316
Am J Physiol Lung Cell Mol Physiol. 2016 Feb 1;310(3):L249-62
pubmed: 26637636
Eur Respir J. 2017 Jul 27;50(1):
pubmed: 28751413
Cardiol Clin. 2016 Aug;34(3):363-74
pubmed: 27443134
Thorax. 2018 Jul;73(Suppl 2):ii1-ii29
pubmed: 29898978
Eur Respir J. 2015 Jan;45(1):201-10
pubmed: 25102964
Vasc Med. 2017 Feb;22(1):44-50
pubmed: 27913777
J Thromb Thrombolysis. 2017 Feb;43(2):166-171
pubmed: 27696084
N Engl J Med. 2014 Apr 10;370(15):1402-11
pubmed: 24716681
Eur Respir J. 2016 Sep;48(3):780-6
pubmed: 27174887
Eur Heart J. 2018 Dec 14;39(47):4175-4181
pubmed: 28575277
Am J Respir Crit Care Med. 2010 Nov 1;182(9):1178-83
pubmed: 20595225
JACC Cardiovasc Interv. 2018 Jul 23;11(14):1401-1410
pubmed: 30025734
N Engl J Med. 2015 Aug 27;373(9):834-44
pubmed: 26308684
Eur Respir J. 2010 May;35(5):1079-87
pubmed: 20032020
Cardiovasc Res. 2018 Jul 1;114(8):1165-1177
pubmed: 29584808
Am J Respir Crit Care Med. 2008 Apr 15;177(8):896-905
pubmed: 18202349
Ann Intern Med. 1991 Sep 1;115(5):343-9
pubmed: 1863023
Future Cardiol. 2018 Jul;14(4):343-353
pubmed: 29792339
Eur Respir J. 2017 Aug 3;50(2):
pubmed: 28775047
J Eval Clin Pract. 2019 Oct;25(5):896-902
pubmed: 30793455
Int J Cardiol. 2017 Jan 15;227:251-256
pubmed: 27839808
J Exp Med. 2012 Oct 22;209(11):1919-35
pubmed: 23071256
Eur Respir J. 2016 Nov;48(5):1369-1376
pubmed: 27471209
J Clin Invest. 2016 Sep 1;126(9):3207-18
pubmed: 27482885
N Engl J Med. 2018 Feb 15;378(7):615-624
pubmed: 29231094
Respir Res. 2011 Mar 17;12:30
pubmed: 21414209
J Cardiovasc Pharmacol. 2015 Nov;66(5):457-67
pubmed: 26230396
J Thromb Thrombolysis. 2016 May;41(4):563-8
pubmed: 26438275
Circulation. 2014 Jan 28;129(4):479-86
pubmed: 24226805
Ther Adv Respir Dis. 2017 Jun;11(6):233-244
pubmed: 28425346
JACC Heart Fail. 2018 Nov;6(11):891-903
pubmed: 30316939
Eur Respir J. 2015 Oct;46(4):903-75
pubmed: 26318161
Ann Emerg Med. 2013 Mar;61(3):330-8
pubmed: 23306454
Am J Respir Crit Care Med. 2010 Jan 15;181(2):158-67
pubmed: 19850946
J Thromb Haemost. 2011 Aug;9(8):1500-7
pubmed: 21645235
Front Physiol. 2018 Apr 09;9:271
pubmed: 29731719
Int J Biochem Cell Biol. 2018 Nov;104:9-13
pubmed: 30189252
Am J Respir Crit Care Med. 2005 Oct 15;172(8):1041-6
pubmed: 16020800
Am J Respir Crit Care Med. 2010 Oct 15;182(8):1065-72
pubmed: 20581171
N Engl J Med. 2013 Aug 29;369(9):799-808
pubmed: 23808982
Am J Respir Crit Care Med. 2017 Mar 1;195(5):583-595
pubmed: 27649290
N Engl J Med. 2012 Apr 5;366(14):1287-97
pubmed: 22449293
Circulation. 2016 Apr 5;133(14):1371-85
pubmed: 26912814
Chest. 2012 Feb;141(2):354-362
pubmed: 21680644
Am J Respir Crit Care Med. 2008 Jul 1;178(1):81-8
pubmed: 18420966
Pulm Circ. 2015 Mar;5(1):101-16
pubmed: 25992275
Am J Respir Cell Mol Biol. 2011 Aug;45(2):311-22
pubmed: 21037114
Eur Respir J. 2016 Feb;47(2):390-3
pubmed: 26828051
Int J Cardiol. 2018 Aug 15;265:223-228
pubmed: 29705651
Eur Respir J. 2018 Aug 30;52(2):
pubmed: 29976656
Growth Factors. 2014 Jun;32(3-4):83-116
pubmed: 24712317
Eur Respir J. 2018 Oct 18;52(4):
pubmed: 30262575
Chest. 2015 Feb;147(2):475-483
pubmed: 25211264
Br J Pharmacol. 2016 Oct;173(19):2859-79
pubmed: 27448286
Eur J Heart Fail. 2016 Mar;18(3):226-41
pubmed: 26995592
Acad Emerg Med. 2015 Jul;22(7):788-95
pubmed: 26113241
Circulation. 2018 May 29;137(22):2371-2389
pubmed: 29444988
Am J Physiol Lung Cell Mol Physiol. 2018 Dec 1;315(6):L965-L976
pubmed: 30211651
Eur Respir J. 2017 Feb 2;49(2):
pubmed: 28007792